SEC 13F Intelligence

Managers / Q1 2020 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$386M
Q1 2020
Positions
21
Filings on Record
30
2019–present window
Filed
May 11, 2020
original filing

Summary

Maso Capital Partners Ltd reported $386M in U.S.-listed holdings across 21 positions for Q1 2020.

The portfolio is heavily concentrated: Allergan alone accounts for 28.8% of reported value.

Compared with Q4 2019, the fund opened 9 new positions and exited 8.

Portfolio Metrics

Turnover
+22.5%
vs prior filed quarter
Top-10 Concentration
+94.3%
share of reported value
Largest Position
+28.8%
Allergan
New / Exited
9 / 8
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Other: 59.6%ADR: 21.5%Common Stock: 18.8%ETP: 0.1%
  • Other · 59.6% · $230M
  • ADR · 21.5% · $83M
  • Common Stock · 18.8% · $73M
  • ETP · 0.1% · $438,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CYEURCYPRESS SEMICONDUCTOR CORPNEW+1.30M1.30M+$30M$30M
KEMUSDKEMET CORPNEW+400.0K400.0K+$10M$10M
MELLANOX TECHNOLOGIES LTDNEW+50.0K50.0K+$6M$6M
7HPHP INCNEW+280.0K280.0K+$5M$5M
PINDUODUO INCNEW+4.00M4.00M+$4M$4M
XRXXEROX HOLDINGS CORPNEW+160.0K160.0K+$3M$3M
JDJD.COM INCNEW+35.0K35.0K+$1M$1M
LUCKIN COFFEE INCNEW+1.00M1.00M+$740,000$740,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

21 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ALLERGAN PLCSHS28.76%$111M627.0K
2CHINA BIOLOGIC PRODUCTS INCCOM25.94%$100M928.0K
32663134DBITAUTO HOLDINGS LTDhistory →SPONSORED ADS10.87%$42M4.04M
4CYOUUSDCHANGYOU.COM LTDhistory →ADS REP CL A8.43%$33M3.04M
5CYEURCYPRESS SEMICONDUCTOR CORPhistory →COM7.85%$30M1.30M
6GNWGENWORTH FINANCIAL INChistory →COM CL A5.59%$22M6.50M
7KEMUSDKEMET CORPhistory →COM NEW2.50%$10M400.0K
8MELLANOX TECHNOLOGIES LTDSHS1.57%$6M50.0K
9NEW FRONTIER HEALTH CORPORD SHS1.50%$6M700.0K
107HPHP INChistory →COM1.26%$5M280.0K
11PINDUODUO INCDEBT1.11%$4M4.00M
12TAKEDA PHARMACEUTICSPONSORED ADS0.85%$3M216.8K
13ACHCACADIA HEALTHCARE CO INCCOM0.81%$3M170.3K
14XRXXEROX HOLDINGS CORPCOM NEW0.78%$3M160.0K
15SOHUSOHU.COM INCSPONSORED ADS0.62%$2M384.0K
16SEA LTDDEBT0.56%$2M2.00M
17JDJD.COM INCSPON ADR CL A0.37%$1M35.0K
18HCMUSDHUTCHISON CHINA MEDITECHSPONSORED ADR0.31%$1M67.7K
19LUCKIN COFFEE INCDEBT0.19%$740,0001.00M
20SPDR S&P 500 ETF TRUSTTR UNIT0.11%$438,0001.7K
21NAKED BRANDS GROUP INCSHS NEW0.00%$11,00021.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.